Javascript must be enabled to continue!
Haemodynamic and anaesthetic management of patients undergoing endovascular therapy for cerebral vasospasm
View through CrossRef
Abstract
Background: Cerebral vasospasm is a common and devastating complication after a subarachnoid haemorrhage (SAH). Current guidelines for treatment recommend hypertension with euvolaemia. Endovascular therapy with cerebral angioplasty and possible administration of intra-arterial vasodilators is indicated in patients who fail medical treatment. The objective of our study was to review the haemodynamic management and anaesthetic care of patients undergoing endovascular therapy for cerebral vasospasm in our institution. Materials and Methods: The medical records of all patients who underwent endovascular therapy for cerebral vasospasm between, April 2006 and September 2012, were reviewed retrospectively. Patients with clinical vasospasm were treated initially by inducing hypertension to systolic pressures of 140 to 170 mmHg; Endovascular treatment was performed, if there was no clinical improvement. Data was collected on blood pressure measurements, anaesthetic management, duration and complications of hypertensive therapy and outcome. The differences in the pre- and post-angioplasty systolic blood pressure were statistically analysed. Results: A total of 45 patients had 47 endovascular interventions, with balloon angioplasty for proximal vessel spasm and 16 (34%) patients had additional intra-arterial injection of a vasodilator agent. Onset of vasospasm was 7 days (range 2-15 days) after SAH. Vasospasm was usually seen in multiple vessels in the same patient regardless of the site of ruptured aneurysm and was present unilaterally in 80% of the patients. All patients had a general anaesthesia for the procedure. Prior to endovascular treatment 68.9% patients required vasopressors, but post angioplasty 93.3% required them. Norepinephrine was the most commonly used (66.2%). Angioplasty was successful in reversing the cerebral vasospasm as assessed by angiography in all patients with no intra-procedure complications. Overall 80% of patients were discharged from hospital to home or to a rehabilitation centre. Conclusion: Cerebral vasospasm affects multiple vessels in the same patient. Despite endovascular therapy being a successful intervention for proximal vessel spasm, most patients still required induced hypertension with even higher levels post angioplasty compared to pre angioplasty.
Title: Haemodynamic and anaesthetic management of patients undergoing endovascular therapy for cerebral vasospasm
Description:
Abstract
Background: Cerebral vasospasm is a common and devastating complication after a subarachnoid haemorrhage (SAH).
Current guidelines for treatment recommend hypertension with euvolaemia.
Endovascular therapy with cerebral angioplasty and possible administration of intra-arterial vasodilators is indicated in patients who fail medical treatment.
The objective of our study was to review the haemodynamic management and anaesthetic care of patients undergoing endovascular therapy for cerebral vasospasm in our institution.
Materials and Methods: The medical records of all patients who underwent endovascular therapy for cerebral vasospasm between, April 2006 and September 2012, were reviewed retrospectively.
Patients with clinical vasospasm were treated initially by inducing hypertension to systolic pressures of 140 to 170 mmHg; Endovascular treatment was performed, if there was no clinical improvement.
Data was collected on blood pressure measurements, anaesthetic management, duration and complications of hypertensive therapy and outcome.
The differences in the pre- and post-angioplasty systolic blood pressure were statistically analysed.
Results: A total of 45 patients had 47 endovascular interventions, with balloon angioplasty for proximal vessel spasm and 16 (34%) patients had additional intra-arterial injection of a vasodilator agent.
Onset of vasospasm was 7 days (range 2-15 days) after SAH.
Vasospasm was usually seen in multiple vessels in the same patient regardless of the site of ruptured aneurysm and was present unilaterally in 80% of the patients.
All patients had a general anaesthesia for the procedure.
Prior to endovascular treatment 68.
9% patients required vasopressors, but post angioplasty 93.
3% required them.
Norepinephrine was the most commonly used (66.
2%).
Angioplasty was successful in reversing the cerebral vasospasm as assessed by angiography in all patients with no intra-procedure complications.
Overall 80% of patients were discharged from hospital to home or to a rehabilitation centre.
Conclusion: Cerebral vasospasm affects multiple vessels in the same patient.
Despite endovascular therapy being a successful intervention for proximal vessel spasm, most patients still required induced hypertension with even higher levels post angioplasty compared to pre angioplasty.
Related Results
Milrinone for refractory cerebral vasospasm with delayed cerebral ischemia
Milrinone for refractory cerebral vasospasm with delayed cerebral ischemia
OBJECTIVE
Intravenous (IV) milrinone is a promising option for the treatment of cerebral vasospasm with delayed cerebral ischemia (DCI) after aneurysmal subarac...
Intracranial Stenting as a Bail-out Option for Posthemorrhagic Cerebral Vasospasm: A Single-Center Experience with Long-Term Follow-Up
Intracranial Stenting as a Bail-out Option for Posthemorrhagic Cerebral Vasospasm: A Single-Center Experience with Long-Term Follow-Up
Abstract
Background: Cerebral vasospasm is a leading cause of morbidity and mortality in patients after subarachnoid hemorrhage (SAH). Endovascular treatment, including int...
Purine nucleoside use as surrogate markers of cerebral ischaemia during local and general anaesthetic carotid endarterectomy
Purine nucleoside use as surrogate markers of cerebral ischaemia during local and general anaesthetic carotid endarterectomy
Objectives:
In periods of cerebral ischaemia, adenosine triphosphate is metabolised, leading to accumulation of adenosine inosine and hypoxanthine. These can be...
Deciphering Popliteal Artery Aneurysm Patient Diversity: Insights From a Cluster Analysis of the POPART Registry
Deciphering Popliteal Artery Aneurysm Patient Diversity: Insights From a Cluster Analysis of the POPART Registry
Background
Popliteal artery aneurysms (PAAs) are the most common peripheral aneurysm. However, due to its rarity, the cumulative body of evidence regarding patient patt...
Determinants of Cerebrovascular Reserve in Patients with Significant Carotid Stenosis
Determinants of Cerebrovascular Reserve in Patients with Significant Carotid Stenosis
Abstract
Introduction
In patients with 70% to 99% diameter carotid artery stenosis cerebral blood flow reserve may be protectiv...
Vasospasm in Cerebral Inflammation
Vasospasm in Cerebral Inflammation
All forms of cerebral inflammation as found in bacterial meningitis, cerebral malaria, brain injury, and subarachnoid haemorrhage have been associated with vasospasm of cerebral ar...
Experimental Study of Cerebral Vasospasm Induced by Serotonin and Oxyhemoglobin in Subarachnoid Hemorrhage
Experimental Study of Cerebral Vasospasm Induced by Serotonin and Oxyhemoglobin in Subarachnoid Hemorrhage
To clarify the mechanism of cerebral vasospasm induced by serotonin (5-HT) and oxyhemoglobin (OxyHb), the authors studied the roles of vasoactive pros taglandins (PGs) and free rad...
Small Cell Lung Cancer and Tarlatamab: A Meta-Analysis of Clinical Trials
Small Cell Lung Cancer and Tarlatamab: A Meta-Analysis of Clinical Trials
Abstract
Introduction
Tarlatamab is a Delta-like ligand 3 (DLL3) -directed bispecific T-cell engager recently approved for use in patients with advanced small cell lung cancer (SCL...

